An interventional study of Therapist-assisted iCBT and Monthly screening with feedback in Depression, sponsored by Lund University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-04.
Sponsored by Lund University · Not applicable, Interventional, and Prevention
Depression treatments including physical activity and sleep management has been shown to relieve depressive symptoms among participants suffering depressive episodes. This study evaluates the potential of these methods as prevention of depressive relapse or recurrence
4,279 studies on the registry are indexed under Recurrence; 988 are open to participants now.
This study's enrollment of 150 is above the median of 50 across 3,374 interventional studies indexed under Recurrence.
Browse Recurrence studies →Lund University is the lead sponsor of 230 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Internet-delivered cognitive behavioral therapy (iCBT), containing physical activity and sleep management for preventing depressive relapse. Monthly depression screening with therapist feedback.
Behavioral: Therapist-assisted iCBT · Behavioral: Monthly screening with feedback
Monthly depression screening with therapist feedback.
Behavioral: Monthly screening with feedback
No intervention, follow-up along with all participants at 6 and 12-months.
13 week long individualized prevention program containing, physical activation, sleep management, tailored cognitive behavioral therapy for individual problems.
Participants are screened with a depression inventory each month and receives feedback from a therapist on the results
Depressive relapse (change in diagnostic status, SCID-I)
Monthly screening via Montgomery-Asberg Depression Rating Scale - Self rated \& Structured Clinical Interview for DSM IV
Time frame: Baseline - 12 months
Change from baseline in depressive symptoms (MADRS-S)
Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.
Time frame: Baseline - 6 months
Change from baseline in depressive symptoms (MADRS-S)
Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.
Time frame: Baseline - 12 months
Change from baseline in depressive symptoms (MADRS-S)
Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated.
Time frame: Monthly, 0-12 months
Change from baseline in health related quality of life (EQ-5D)
Health related quality of life will be measured by an internet based version of the EQ-5D.
Time frame: Baseline - 3 months
Change from baseline in health related quality of life (EQ-5D)
Health related quality of life will be measured by an internet based version of the EQ-5D.
Time frame: Baseline - 6 months
Change from baseline in health related quality of life (EQ-5D)
Health related quality of life will be measured by an internet based version of the EQ-5D.
Time frame: Baseline - 9 months
Change from baseline in health related quality of life (EQ-5D)
Health related quality of life will be measured by an internet based version of the EQ-5D.
Time frame: Baseline - 12 months
Change from baseline in Outcomes Questionnaire 45 (OQ-45)
The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.
Time frame: Baseline - 3 months
Change from baseline in Outcomes Questionnaire 45 (OQ-45)
The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.
Time frame: Baseline - 6 months
Change from baseline in Outcomes Questionnaire 45 (OQ-45)
The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.
Time frame: Baseline - 9 months
Change from baseline in Outcomes Questionnaire 45 (OQ-45)
The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time.
Time frame: Baseline - 12 months
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
The International Physical Activity Questionnaire is a measure of physical activity
Time frame: Baseline - 3 months
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
The International Physical Activity Questionnaire is a measure of physical activity
Time frame: Baseline - 6 months
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
The International Physical Activity Questionnaire is a measure of physical activity
Time frame: Baseline - 9 months
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
The International Physical Activity Questionnaire is a measure of physical activity
Time frame: Baseline - 12 months
Morisky Medication Adherence Scale (MMAS-8)
Self-reported measure of medication adherence
Time frame: Baseline - 3 months
Morisky Medication Adherence Scale (MMAS-8)
Self-reported measure of medication adherence
Time frame: Baseline - 6 months
Morisky Medication Adherence Scale (MMAS-8)
Self-reported measure of medication adherence
Time frame: Baseline - 9 months
Morisky Medication Adherence Scale (MMAS-8)
Self-reported measure of medication adherence
Time frame: Baseline - 12 months
Insomnia Severity Index (ISI)
Insomnia issues
Time frame: Baseline - 3 months
Insomnia Severity Index (ISI)
Insomnia issues
Time frame: Baseline - 6 months
Insomnia Severity Index (ISI)
Insomnia issues
Time frame: Baseline - 9 months
Insomnia Severity Index (ISI)
Insomnia issues
Time frame: Baseline - 12 months
Alcohol Use Disorder Identification Test (AUDIT)
Time frame: Baseline - 3 months
Alcohol Use Disorder Identification Test (AUDIT)
Time frame: Baseline - 6 months
Alcohol Use Disorder Identification Test (AUDIT)
Time frame: Baseline - 9 months
Alcohol Use Disorder Identification Test (AUDIT)
Time frame: Baseline - 12 months
Time to depressive relapse
Time to depressive relapse is recorded as secondary outcome variable
Time frame: Baseline - 12 months
Self reported treatment seeking
Treatment seeking among participants is recorded as secondary outcome variable
Time frame: Baseline - 12 months
This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lund University